Abstract
Topical therapy still plays an important role in the treatment of onychomycosis despite the availability of excellent oral drugs. Presented here are the data from the clinical studies of ciclopirox nail lacquer performed in the United States. This preparation has been accepted as safe and effective in the treatment of onychomycosis in many countries outside the United States. It is well known that the disease can be extensive and difficult to treat in many patients, and the response to therapy is very slow no matter what agent is used.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Scher, R. (1999). Clinical Efficacy of Topical Ciclopirox Nail Lacquer: Double-Blind United States Studies on Onychomycosis. In: Shuster, S. (eds) Hydroxy-Pyridones as Antifungal Agents with Special Emphasis on Onychomycosis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58401-5_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-58401-5_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-65494-0
Online ISBN: 978-3-642-58401-5
eBook Packages: Springer Book Archive